Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Endoscopic Studies I: Bronchoscopy and Thoracoscopy01:30

Endoscopic Studies I: Bronchoscopy and Thoracoscopy

Endoscopy is a non-surgical medical technique used to examine a person's internal organs and vessels. This lesson will focus on two types of endoscopic studies: bronchoscopy and thoracoscopy.
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due to...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An experience with cardiopulmonary bypass in HIV-infected patients.

Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners·2006
Same author

Pneumonectomy in children.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2002
Same author

Comparative safety and efficacy of Bioplasma FDP versus single-donor fresh-dried plasma in cardiopulmonary bypass patients.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2002
Same author

Pulmonary angiography and embolization for severe hemoptysis due to cavitary pulmonary tuberculosis.

Cardiovascular and interventional radiology·1999
Same author

Thoracoscopic evacuation of dead hydatid cyst.

The Journal of thoracic and cardiovascular surgery·1996
Same author

Triage in the surgical investigation of patients with suspected bronchial carcinoma.

South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie·1986

Related Experiment Video

Updated: Jul 16, 2026

Mouse Pneumonectomy Model of Compensatory Lung Growth
09:22

Mouse Pneumonectomy Model of Compensatory Lung Growth

Published on: December 17, 2014

Pneumonectomy for inflammatory lung disease.

D F Blyth1

  • 1Department of Cardio-thoracic Surgery, University of Natal Medical School, Durban, South Africa. blyth@wwh.und.ac.za

European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|October 12, 2000
PubMed
Summary

Pneumonectomy for inflammatory lung disease is safe and effective, with low mortality and morbidity. Adequate anti-tuberculosis drug coverage can improve outcomes for patients with tuberculosis.

More Related Videos

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
07:27

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Related Experiment Videos

Last Updated: Jul 16, 2026

Mouse Pneumonectomy Model of Compensatory Lung Growth
09:22

Mouse Pneumonectomy Model of Compensatory Lung Growth

Published on: December 17, 2014

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
07:27

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome

Published on: January 23, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Area of Science:

  • Thoracic Surgery
  • Pulmonary Medicine
  • Infectious Diseases

Background:

  • Pneumonectomy for inflammatory lung disease carries risks.
  • Assessing the risk/benefit ratio of pneumonectomy is crucial.

Purpose of the Study:

  • To evaluate the safety and efficacy of pneumonectomy for inflammatory lung disease.
  • To assess the risk/benefit ratio of the departmental policy on pneumonectomy.

Main Methods:

  • Retrospective analysis of patients undergoing pneumonectomy for inflammatory lung disease.
  • Inclusion of two 2-year periods (1991-1992 and 1996-1997).
  • Analysis of clinical indications, radiographic findings, morbidity, and mortality rates.

Main Results:

  • 155 patients underwent pneumonectomy; 72% had a history of tuberculosis.
  • Mortality rate was 1.2% (2 patients); morbidity was 23%.
  • Post-pneumonectomy empyema occurred in 14.8% of patients, particularly those with pre-existing empyema.

Conclusions:

  • Pneumonectomy for inflammatory lung disease is a safe procedure with good outcomes.
  • Adequate pre-operative and operative anti-tuberculosis drug coverage may improve results in tuberculosis patients.
  • Pneumonectomy in children was uncomplicated; pneumonectomy in active tuberculosis had manageable risks.